Britain’s GSK backs CEO after pressure from activist Elliott By Reuters

2/2 © Reuters. FILE PHOTO: GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain, October 9, 2017. REUTERS/Toby Melville 2/2 (Reuters) – GSK on Friday backed Chief Executive Emma Walmsley to continue leading the pharmaceuticals group after it spins off its consumer healthcare arm, responding to activist investor


2/2

© Reuters. FILE PHOTO: GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain, October 9, 2017. REUTERS/Toby Melville

2/2

(Reuters) – GSK on Friday backed Chief Executive Emma Walmsley to continue leading the pharmaceuticals group after it spins off its consumer healthcare arm, responding to activist investor Elliott’s proposals for the British company.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





Source link

The Fund Times
ADMINISTRATOR
PROFILE

Posts Carousel

Leave a Comment

Your email address will not be published. Required fields are marked with *

Latest Posts

Top Authors

Most Commented

Featured Videos